O Bruyère, N Burlet, PD Delmas, R Rizzoli, C … - BMC Musculoskeletal Disorders, 2008 - biomedcentral.com The following interventions were taken into consideration: avocado/soybean
unsaponifiables, chondroitin sulfate, diacereine, glucosamine sulfate,
hyaluronic acid, oral calcitonin, risedronate, strontium ranelate. ... Cited by 6 - Related articles - Cached - All 9 versions
RM Rozendaal, EJ Uitterlinden, G van Osch, … - Osteoarthritis and Cartilage, 2009 - Elsevier We randomized 222 patients with hip OA that met one of the American College of
Rheumatology criteria to either 1500 mg of oral GS or placebo once daily for 2
years. Subgroup analyses were predefined for radiographic severity ... Cited by 2 - Related articles - All 20 versions
DT Felson - Nature Clinical Practice Rheumatology, 2008 - 万方数据资源系统 Clinical trials of glucosamine for the treatment of patients with osteoarthritis
have produced conflicting results that seem to correlate with the form of
glucosamine used. Trials of glucosamine hydrochloride have produced data ... Cited by 1 - Related articles - All 4 versions
RC Gupta, D Bagchi, P Skaggs, R Burke, K … - J Vet Pharmacol Ther, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 1 - Related articles
RM Rozendaal, CD De Fouw, SP Willemsen, … - Hip Osteoarthritis in General Practice - publishing.eur.nl 82 aBstRaCt Objectives The course and prognostic factors of hip osteoarthritis
(OA) are poorly investigated. The aim of this study was to describe the course
of pain and to analyse prognostic factors of progression of pain and ... Cited by 1 - Related articles - View as HTML
[CITATION] Last literature review version 17.1: Thu Jan 01 00: 00: 00 GMT 2009| This topic last …
CME Tracker - members.medscape.com In conclusion, in the benefit/risk ratio, the use of chondroitin sulfate,
diacereine, glucosamine sulfate, avocado/soybean unsaponifiables and hyaluronic
acid could be of potential interest for the symptomatic management of OA. Related articles - Cached
A Statements - members.medscape.com Olivier Bruyère, PhD WHO Collaborating Center for the Public Health Aspect of
Musculoskeletal Disorders, University of Liege, Liege, Belgium Disclosure:
Olivier Bruyère, PhD, has disclosed that he has received consulting fees ... Related articles - Cached - All 4 versions
RM Rozendaal, A Burdorf, SP Willemsen, BW … - Hip Osteoarthritis in General Practice - publishing.eur.nl 118 aBstRaCt Objective The aim of this study was to assess the medical
consumption of primary care patients with hip osteoarthritis, and the associated
determinants and costs. Methods 222 Primary care patients meeting the ... Related articles - View as HTML
CME Tracker - members.medscape.com Following the GRADE system, the study design for all trials included in the
review of evidence for chondroitin sulfate, diacereine, glucosamine sulfate,
hyaluronic acid and risedronate was randomised controlled trial which is ... Related articles - Cached
